spacer
home > > autumn 2020 > neoantigens: ip considerations for an emerging class of cancer immunotherapy
PAY PER VIEW SERVICE

 

Dear guest!

article: Neoantigens: IP Considerations for an Emerging Class of Cancer Immunotherapy
format: Adobe Acrobat PDF file
cost: £

spacer

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

 
News and Press Releases

Almost 70% of Doctors Say Covid-19 Vaccine Rates Would Be Higher If They Could Administer to Their Own Patients, New Survey Shows

With variants on the rise and the continued need for vaccinations, a new global survey of physicians finds that many doctors believe that they may be the key to boosting vaccination rates as they are an important source of information, comfort, and reassurance for COVID-19 vaccine-reluctant patients.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement